Cholangitis is inflammation (swelling) in the bile duct. Treatment depends on your symptoms and whether you have chronic or acute cholangitis.

Primary biliary cholangitis (PBC) ... safety and tolerability of CNP-104 in adults with PBC in a phase 2 proof-of-concept study (ClinicalTrials.gov Identifier: NCT05104853).

Hepatology Communications Publishes Data from Mirum’s LIVMARLI in Primary Sclerosing Cholangitis. ... The CAMEO study was the first proof-of-concept study evaluating an ileal bile acid ...

Primary biliary cholangitis is a rare, chronic cholestatic liver disease with increasing prevalence worldwide that occurs predominantly in women 40 years of age or older. 1,2 The disease is ...

SAN DIEGO — Quantitative magnetic resonance cholangiopancreatography may help assess changes in the biliary tree and aid monitoring of patients with primary sclerosing cholangitis, according to ...

Seladelpar is a drug candidate for the treatment of primary biliary cholangitis that selectively activates PPARδ. 12 PPARδ is unique among PPAR isotypes, with broad expression in cells that play ...

Biotechnology company COUR Pharmaceuticals announced that the FDA granted fast track designation to CNP-104, an investigational therapy for the treatment of primary biliary cholangitis, according ...

Immunic, a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced ...